Hendrik Heers

853 total citations
39 papers, 417 citations indexed

About

Hendrik Heers is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Hendrik Heers has authored 39 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 11 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Hendrik Heers's work include Renal cell carcinoma treatment (5 papers), Kidney Stones and Urolithiasis Treatments (5 papers) and Palliative Care and End-of-Life Issues (5 papers). Hendrik Heers is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Kidney Stones and Urolithiasis Treatments (5 papers) and Palliative Care and End-of-Life Issues (5 papers). Hendrik Heers collaborates with scholars based in Germany, United Kingdom and Austria. Hendrik Heers's co-authors include Benjamin W. Turney, Rainer Hofmann, Axel Hegele, Thomas J. Littlejohns, Naomi Laura Neal, Ben Turney, Kathryn E. Bradbury, Naomi E. Allen, Jörg Hänze and Tobias Boeselt and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Urology.

In The Last Decade

Hendrik Heers

32 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hendrik Heers Germany 11 273 130 61 58 49 39 417
Doo Yong Chung South Korea 14 384 1.4× 136 1.0× 122 2.0× 47 0.8× 15 0.3× 54 552
Andreas Bourdoumis United Kingdom 12 198 0.7× 132 1.0× 109 1.8× 33 0.6× 23 0.5× 35 370
Xiaomin Gao China 12 135 0.5× 49 0.4× 77 1.3× 68 1.2× 23 0.5× 26 359
Harry S. Clarke United States 13 243 0.9× 33 0.3× 118 1.9× 43 0.7× 15 0.3× 43 465
Tongwen Ou China 11 132 0.5× 76 0.6× 70 1.1× 49 0.8× 5 0.1× 33 316
Xiaoyan Fang China 13 107 0.4× 138 1.1× 39 0.6× 132 2.3× 103 2.1× 51 448
Scott M. Castle United States 11 262 1.0× 43 0.3× 144 2.4× 180 3.1× 19 0.4× 25 435
Carmen González Enguita Spain 11 176 0.6× 41 0.3× 97 1.6× 111 1.9× 39 0.8× 101 463
Samuel D. Pettersson United States 10 151 0.6× 53 0.4× 95 1.6× 39 0.7× 21 0.4× 53 329

Countries citing papers authored by Hendrik Heers

Since Specialization
Citations

This map shows the geographic impact of Hendrik Heers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Heers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Heers more than expected).

Fields of papers citing papers by Hendrik Heers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik Heers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Heers. The network helps show where Hendrik Heers may publish in the future.

Co-authorship network of co-authors of Hendrik Heers

This figure shows the co-authorship network connecting the top 25 collaborators of Hendrik Heers. A scholar is included among the top collaborators of Hendrik Heers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hendrik Heers. Hendrik Heers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heers, Hendrik, et al.. (2025). Do We Have a Knowledge Gap with Our Patients?—On the Problems of Knowledge Transfer and the Implications at the End of Life. International Journal of Environmental Research and Public Health. 22(2). 247–247.
2.
3.
Schneidewind, Laila, et al.. (2024). Enhancing Human Papillomavirus Vaccination Rates through Better Knowledge? Insights from a Survey among German Medical Students. Urologia Internationalis. 108(2). 153–158. 1 indexed citations
4.
5.
Heers, Hendrik, Josef Gut, Rainer Hofmann, et al.. (2024). Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach. World Journal of Urology. 42(1). 353–353. 3 indexed citations
6.
Heers, Hendrik, et al.. (2023). End of life care: Preferences of patients with advanced urologic and dermatologic malignancies.. Journal of Clinical Oncology. 41(16_suppl). e24006–e24006.
7.
Heers, Hendrik, et al.. (2023). Wünsche und Vorsorgeplanung für das Lebensende von Patienten mit fortgeschrittenem Hautkrebs. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(10). 1148–1156.
8.
Librizzi, Damiano, Markus Luster, Hendrik Heers, et al.. (2023). Adoption of Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020. European Journal of Nuclear Medicine and Molecular Imaging. 50(7). 2188–2195. 7 indexed citations
9.
Mahnken, Andreas H., et al.. (2023). Focal Therapy for Renal Cancer: Comparative Trends in the USA and Germany from 2006 to 2020 and Analysis of the German Health Care Landscape. Urologia Internationalis. 107(4). 396–405. 6 indexed citations
10.
Heers, Hendrik, et al.. (2022). Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome. Immunologic Research. 70(5). 698–707. 11 indexed citations
11.
Heers, Hendrik, et al.. (2022). Alternative- and focal therapy trends for prostate cancer: a total population analysis of in-patient treatments in Germany from 2006 to 2019. World Journal of Urology. 40(7). 1645–1652. 13 indexed citations
12.
Littlejohns, Thomas J., Naomi Laura Neal, Kathryn E. Bradbury, et al.. (2019). Fluid Intake and Dietary Factors and the Risk of Incident Kidney Stones in UK Biobank: A Population-based Prospective Cohort Study. European Urology Focus. 6(4). 752–761. 90 indexed citations
13.
Rexin, Peter, Jörg Hänze, Hendrik Heers, et al.. (2018). The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder Cancer. Anticancer Research. 38(5). 2749–2754. 11 indexed citations
14.
Hofmann, Rainer, et al.. (2018). mRCC Outcome in the Treatment of Metastatic Renal Cell Carcinoma – A German Single-center Real-world Experience. In Vivo. 32(6). 1617–1622. 10 indexed citations
15.
Heers, Hendrik, Josef Gut, Axel Hegele, et al.. (2018). Non-invasive Detection of Bladder Tumors Through Volatile Organic Compounds: A Pilot Study with an Electronic Nose. Anticancer Research. 38(2). 833–837. 29 indexed citations
16.
Heers, Hendrik, Patrick de Geeter, Peter J. Goebell, et al.. (2017). Vinflunine in the Τreatment of Upper Tract Urothelial Carcinoma – Subgroup Analysis of an Observational Study. Anticancer Research. 37(11). 6437–6442. 4 indexed citations
17.
Heers, Hendrik, Annette Ramaswamy, & Rainer Hofmann. (2017). A Case of Churg-Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis) of the Urinary Bladder. Urology. 108. 7–10. 1 indexed citations
18.
Heers, Hendrik, et al.. (2015). Lymphoceles Post-Radical Retropubic Prostatectomy: A Retrospective Evaluation of Epidemiology, Risk Factors and Outcome. Urologia Internationalis. 95(4). 400–405. 15 indexed citations
19.
Heers, Hendrik, et al.. (2015). Does visualisation during urethrocystoscopy provide pain relief? Results of an observational study. BMC Urology. 15(1). 56–56. 8 indexed citations
20.
Hegele, Axel, et al.. (2013). Nachwuchs gewinnen – aber wie?. Der Urologe. 53(2). 236–240. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doo Yong Chung Breakdown of academic impact, for papers by Andreas Bourdoumis Breakdown of academic impact, for papers by Xiaomin Gao Breakdown of academic impact, for papers by Harry S. Clarke Breakdown of academic impact, for papers by Tongwen Ou Breakdown of academic impact, for papers by Xiaoyan Fang Breakdown of academic impact, for papers by Scott M. Castle Breakdown of academic impact, for papers by Carmen González Enguita Breakdown of academic impact, for papers by Samuel D. Pettersson
Rankless by CCL
2026